Thymosin Alpha-1 and Cytokine Synergy: How This Peptide Amplifies Immune Responses

Thymosin alpha-1 synergizes with cytokines (IFN-alpha, IFN-gamma, IL-2, IL-12) to amplify immune responses beyond what either achieves alone — the molecular basis for its combination immunotherapy success.

Naylor, Paul H et al.·Annals of the New York Academy of Sciences·2007·Moderate EvidenceReview
RPEP-01272ReviewModerate Evidence2007RETHINKTHC RESEARCH DATABASErethinkthc.com/research

Quick Facts

Study Type
Review
Evidence
Moderate Evidence
Sample
Not reported

What This Study Found

Thymosin alpha-1 synergizes with IFN-alpha, IFN-gamma, IL-2, and IL-12 to amplify T-cell, NK cell, and dendritic cell responses through complementary signaling pathways — explaining why combination therapy outperforms monotherapy for infections and cancer.

Key Numbers

How They Did This

review study on thymosin-alpha-1, immune-function.

Why This Research Matters

Relevant for thymosin-alpha-1, immune-function, cancer.

The Bigger Picture

Advances peptide research.

What This Study Doesn't Tell Us

See abstract.

Questions This Raises

  • ?Further research needed.
  • ?Clinical translation to evaluate.

Trust & Context

Key Stat:
Key finding Thymosin alpha-1 synergizes with IFN-alpha, IFN-gamma, IL-2, and IL-12 to amplify T-cell, NK cell, and dendritic cell responses through complementary
Evidence Grade:
moderate evidence.
Study Age:
Published in 2007.
Original Title:
Immunopharmacology of thymosin alpha1 and cytokine synergy.
Published In:
Annals of the New York Academy of Sciences, 1112, 235-44 (2007)
Database ID:
RPEP-01272

Evidence Hierarchy

Meta-Analysis / Systematic Review
Randomized Controlled Trial
Cohort / Case-Control
Cross-Sectional / ObservationalSnapshot without intervening
This study
Case Report / Animal Study

Summarizes existing research on a topic.

What do these levels mean? →

Frequently Asked Questions

What was studied?

Thymosin Alpha-1 and Cytokine Synergy: How This Peptide Amplifies Immune Responses

What was found?

Thymosin alpha-1 synergizes with cytokines (IFN-alpha, IFN-gamma, IL-2, IL-12) to amplify immune responses beyond what either achieves alone — the molecular basis for its combination immunotherapy success.

Read More on RethinkPeptides

Cite This Study

RPEP-01272·https://rethinkpeptides.com/research/RPEP-01272

APA

Naylor, Paul H; Quadrini, Karen; Garaci, Enrico; Rasi, Guido; Hadden, John W. (2007). Immunopharmacology of thymosin alpha1 and cytokine synergy.. Annals of the New York Academy of Sciences, 1112, 235-44.

MLA

Naylor, Paul H, et al. "Immunopharmacology of thymosin alpha1 and cytokine synergy.." Annals of the New York Academy of Sciences, 2007.

RethinkPeptides

RethinkPeptides Research Database. "Immunopharmacology of thymosin alpha1 and cytokine synergy." RPEP-01272. Retrieved from https://rethinkpeptides.com/research/naylor-2007-immunopharmacology-of-thymosin-alpha1

Access the Original Study

Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.

This study breakdown was produced by the RethinkPeptides research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.